Survival status | Total N = 606 | High muscle mass (AST/ALT) | Low muscle mass (AST/ALT) | P-value | High muscle mass (Cr/CysC*100) | Low muscle mass (Cr/CysC*100) | P-value |
---|---|---|---|---|---|---|---|
1 year, n (%) | < 0.001 | < 0.001 | |||||
survival | 339(55.94) | 191(63.04) | 148(48.84) | 207(68.09) | 132(43.71) | ||
death | 267(44.06) | 112(36.96) | 155(51.16) | 97(31.91) | 170(56.29) | ||
2 years, n (%) | 0.001 | < 0.001 | |||||
survival | 316(52.15) | 178(58.75) | 138(45.54) | 196(64.47) | 120(39.74) | ||
death | 290(47.85) | 125(41.25) | 165(54.46) | 108(35.53) | 182(60.26) | ||
3 years, n (%) | 0.003 | < 0.001 | |||||
survival | 310(51.16) | 173(57.1) | 137(45.21) | 193(63.49) | 117(38.74) | ||
death | 296(48.84) | 130(42.9) | 166(54.79) | 111(36.51) | 185(61.26) |